Obesity-linked metabolic diseases, such as type 2 diabetes and cardiovascular disease, are associated with a state of low-grade inflammation. Recent research has elucidated many of the mediators and mechanisms that are involved in inflammation-associated metabolic disease. This Focus features articles that explore the interplay between metabolism and the immune system, explaining how inflammation drives type 2 diabetes, how fat-tissue-derived mediators are involved in inflammation and metabolic disease, and how T cell metabolism is linked to T cell fate.